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Abstract. 
 
Actin capping protein (CP) binds barbed 
ends of actin ﬁlaments to regulate actin assembly. CP is 
an 
 
a
 
/
 
b
 
 heterodimer. Vertebrates have conserved iso-
forms of each subunit. Muscle cells contain two 
 
b
 
 iso-
forms. 
 
b
 
1 is at the Z-line; 
 
b
 
2 is at the intercalated disc 
and cell periphery in general. To investigate the func-
tions of the isoforms, we replaced one isoform with an-
other using expression in hearts of transgenic mice.
Mice expressing 
 
b
 
2 had a severe phenotype with ju-
venile lethality. Myoﬁbril architecture was severely dis-
rupted. The 
 
b
 
2 did not localize to the Z-line. Therefore, 
 
b
 
1 has a distinct function that includes interactions at 
the Z-line. Mice expressing 
 
b
 
1 showed altered mor-
phology of the intercalated disc, without the lethality or 
myoﬁbril disruption of the 
 
b
 
2-expressing mice.
The in vivo function of CP is presumed to involve 
binding barbed ends of actin ﬁlaments. To test this hy-
pothesis, we expressed a 
 
b
 
1 mutant that poorly binds 
actin. These mice showed both myoﬁbril disruption and 
intercalated disc remodeling, as predicted.
Therefore, CP
 
b
 
1 and CP
 
b
 
2 each have a distinct func-
tion that cannot be provided by the other isoform. 
CP
 
b
 
1 attaches actin ﬁlaments to the Z-line, and CP
 
b
 
2 
organizes the actin at the intercalated discs. 
Key words: isoform • heart • cardiomyopathy • Z line 
• sarcomere
 
C
 
APPING
 
 protein (CP)
 
1
 
 is a heterodimer composed of
 
a
 
 and 
 
b
 
 subunits, which binds to the barbed ends
of actin filaments. Lower organisms, including
 
Saccharomyces cerevisiae
 
, 
 
Caenorhabditis elegans
 
, and
 
Drosophila melanogaster
 
, have one gene and one isoform
for each of the CP 
 
a
 
 and 
 
b
 
 subunits (Amatruda et al.,
1990; Waddle et al., 1993; Hopmann et al., 1996). In con-
trast, vertebrates contain three 
 
a
 
 subunit isoforms en-
coded by three different genes, and three 
 
b
 
 subunit iso-
forms (
 
b
 
1, 
 
b
 
2, and 
 
b
 
3) that are produced by alternative
splicing from one gene (Schafer et al., 1994; Hart et al.,
1997; von Bulow et al., 1997).
The 
 
a
 
3 and 
 
b
 
3 isoforms are expressed specifically in
male germ cells. The 
 
b
 
3 isoform is identical to the 
 
b
 
2 iso-
form with the addition of 29 amino acids at the NH
 
2
 
 termi-
nus (von Bulow et al., 1997). The 
 
b
 
1 and 
 
b
 
2 isoforms are
identical for their first 246 amino acids. Their COOH-ter-
minal ends (
 
b
 
1, 31 residues; 
 
b
 
2, 26 residues) are different
(Hug et al., 1992; Schafer et al., 1994).
Several lines of evidence support the hypothesis that the
 
b
 
1 and 
 
b
 
2 isoforms have distinct biochemical and cellular
functions that are conserved across vertebrates. First, the
COOH-terminal sequences that distinguish the 
 
b
 
1 and 
 
b
 
2
isoforms are highly conserved across vertebrates (Schafer
et al., 1994). Second, the 
 
b
 
 isoforms display tissue specific
expression. The 
 
b
 
1 isoform is predominantly expressed in
muscle tissue, whereas the 
 
b
 
2 isoform is the predominant
isoform of nonmuscle tissues (Schafer et al., 1994; Hart
et al., 1997). Third, the 
 
b
 
 isoforms display distinct subcel-
lular localizations within a single cell. In striated muscle
cells, 
 
b
 
1 localizes to the Z-lines of sarcomeres and 
 
b
 
2 lo-
calizes to cell–cell junctions and the plasma membrane in
general (Schafer et al., 1994).
The presumed functional differences between CP
 
b
 
1 and
CP
 
b
 
2 that might account for the localization differences
and the sequence conservation remain undefined. The
COOH-terminal region of CP
 
b
 
, the region where the iso-
forms differ, is necessary for binding to actin. However,
CP
 
b
 
1 and CP
 
b
 
2 bind to actin with essentially identical af-
finities and kinetics in vitro (Schafer et al., 1996). Also,
CP
 
b
 
1 and CP
 
b
 
2 are both inhibited by PIP
 
2
 
, the only
known regulator of CP (Schafer et al., 1996).
We wish to understand why vertebrates evolved to have
conserved CP
 
b
 
 isoforms that are placed in different sub-
cellular locations in myocytes. One hypothesis is that the
 
b
 
1 and 
 
b
 
2 isoforms perform different functions related to
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1. 
 
Abbreviations used in this paper:
 
 
 
a
 
-MyHC, 
 
a
 
-myosin heavy chain; CP,
capping protein. 
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the organization of actin filaments of myocytes. The 
 
b
 
1
isoform may have a function that the 
 
b
 
2 isoform does not
have, 
 
b
 
2 may have a function that the 
 
b
 
1 does not have, or
both may be the case. The first part of this hypothesis pre-
dicts that the 
 
b
 
2 isoform cannot function in place of 
 
b
 
1 in
the organization of thin filaments at the Z-line of the sar-
comere. Replacement of the 
 
b
 
1 isoform with the 
 
b
 
2 iso-
form would cause improper assembly of the actin fila-
ments of the sarcomeres, altering the organization of the
sarcomeres and the architecture of the myofibrils. The sec-
ond part of the hypothesis predicts that the 
 
b
 
1 isoform
cannot function in place of the 
 
b
 
2 isoform in the organiza-
tion of thin filaments at the intercalated discs. Replace-
ment of the 
 
b
 
1 isoform with the 
 
b
 
2 isoform would alter ac-
tin filament assembly at intercalated discs, leading to
altered intercalated disc structure.
An alternative hypothesis is that the 
 
b
 
1 and 
 
b
 
2 protein
isoforms have identical functional abilities within the myo-
cyte, but the alternative transcripts have different regula-
tory sequences that lead to different expression programs.
This hypothesis predicts that the CP
 
b
 
 protein isoforms are
functionally interchangeable. In this case, replacement of
one protein isoform with the other isoform would not
change the actin organization.
To determine if one isoform can function in place of the
other in cardiac myocytes, we generated transgenic mice
that overexpress CP
 
b
 
1 or CP
 
b
 
2 in the ventricles of the
murine heart. We used a cardiac-specific promoter, 
 
a
 
-myosin
heavy chain (
 
a
 
-MyHC), that turns on in the ventricles at
birth.
CP is an 
 
a
 
/
 
b
 
 heterodimer. Single subunits are unstable
in vivo and show little or no function in vitro and in vivo,
based on results involving mutations, antisense, and ex-
pression studies in yeast, 
 
Dictyostelium
 
, and cultured ver-
tebrate muscle cells and fibroblasts (Amatruda et al., 1992;
Hug et al., 1992, 1995; Schafer et al., 1992). Therefore, in-
creasing the expression of one isoform should lead to a re-
placement of the endogenous isoform in the functional 
 
a
 
/
 
b
 
heterodimer.
We found that overexpression of the 
 
b
 
2 isoform re-
sulted in severe disruption of myofibril architecture. Over-
expression of the 
 
b
 
1 isoform resulted in an altered archi-
tecture of the intercalated disc. These results indicate that
the isoforms do have different functions. Overexpressed
CP
 
b
 
2 does not go to the Z-line; therefore, the unique
function of CP
 
b
 
1 may involve its interaction with compo-
nents of the Z-line. Likewise, overexpressed CP
 
b
 
1 does
not go to the intercalated disc; therefore, the unique func-
tion of CP
 
b
 
2 may involve its interaction with components
of the intercalated disc. Actin binding appears to be neces-
sary for the function of both isoforms in both locations.
 
Materials and Methods
 
Construction of the
 
 
 
a
 
-MyHC-CP
 
b
 
1, CP
 
b
 
2, and
CP
 
b
 
1-L262R Transgene
 
The coding regions of murine CP
 
b
 
1 and -
 
b
 
2 (GenBank/EMBL/DDBJ
accession no. U10406, U10407) were amplified using PCR with 5
 
9
 
GCGCGTCGACGCCACCATGAGCGATCAGC 3
 
9
 
 (primer 1) and 5
 
9
 
GCGCGTCGACAGAGATGGCGCTGCGTGGTC 3
 
9
 
 (primer 2) and
inserted downstream of the 
 
a
 
-MyHC promoter in a unique SalI restriction
site from plasmid clone 26, provided by Dr. J. Robbins (University of
 
Cincinnati; Palermo et al., 1995). A 611-bp HindIII–EcoRI fragment con-
taining the human growth hormone poly(A) signal was at the 3
 
9
 
 end of the
 
a
 
-MyHC/CP
 
b
 
 constructs. A third construct, 
 
a
 
-MyHC-
 
b
 
1L262R, which
contains a T to G transversion at base 839, changing amino acid 262 from
leucine to arginine, was amplified using PCR. Primer 1 and 5
 
9 
 
CAG-
CACTTGAGAACGTTCCCTCTGCAACTGC 3
 
9
 
 were used to make
one product. Primer 2 and 5
 
9 
 
GCAGTTGCAGAGGGAACGTTCT-
CAAGTGCTG 3
 
9
 
 were used to make another product. The products
were then used as template in a final PCR reaction with primers 1 and 2 to
generate the full-length product.
The complete open reading frames of the recombinant plasmids were
sequenced using specific primers. No changes were present. To prepare
the DNA constructs for injection, plasmid containing 
 
a
 
-MyHC promoter/
cDNA construct was digested with NotI to release the transgene DNA
fragment. The fragment was separated from the vector by agarose gel
electrophoresis, purified using QiaexII (Qiagen), phenol/chloroform ex-
tracted, alcohol precipitated, resuspended, and dialyzed against endotoxin
free 5 mM Tris, pH 8.0, 1 mM EDTA. The DNA was quantitated before
injection by optical density and agarose gel electrophoresis using a known
standard.
 
Production of Transgenic Mice
 
The linearized transgene constructs were microinjected into the male
pronuclei of one-cell embryos, which were then surgically reimplanted
into pseudopregnant female mice. DNA was purified from the tail clips
of progeny by digestion at 55
 
8
 
C overnight with 50 mM Tris-HCL, pH 8.0,
100 mM EDTA, 0.5% SDS, and 500 mg/ml proteinase K (Boehringer
Mannheim Corp.). DNA was purified using Phase Lock Gel I (Heavy; 5
Prime-3 Prime) and resuspended in 100 ml of 10 mM Tris, pH 8.0, 1 mM
EDTA. Progeny were screened for the presence of the transgene by
genomic Southern blot analysis using a 32P-labeled 1.2 kb SalI–EcoRI
fragment of the a-MyHC promoter. Three different founder lines were
identified for a-MyHC-wtb1, three for a-MyHC-wtb2, and four for
a-MyHC-b1L262R. Founders were bred against a C57BL/6 background
and studied as N1 heterozygotes. Founder lines with the greatest expres-
sion and most severe phenotypes are described in this paper.
Transgene copy number was quantitated for the progeny of the three
founder lines for a-MyHC-wtb1 by PhosphoImager analysis of genomic
Southern blots. The transgene copy numbers for lines 1, 2, and 3 were 2, 4,
and 7, respectively. Genomic DNA digested with EcoRI and SalI were
probed with a 32P-labeled 1.2-kb SalI–EcoRI fragment of the a-MyHC
promoter. The transgene generated a 1.7-kb band, and the endogenous
a-MyHC gene generated a 2.5-kb band. The intensities of the radioactiv-
ity associated with each band were measured with the PhosphoImager,
and the endogenous gene was used as the standard for a single-copy gene.
For the a-MyHC-wtb2 and a-MyHC-b1L262R transgenic lines, genomic
Southern blots were evaluated qualitatively and showed transgene copy
numbers of 2 to 10, based on the intensity of the transgene band relative
to the endogenous gene band.
Determination of Expression Levels
RNA. To evaluate transgene expression by Northern blot analysis, hearts
were dissected from 3-wk-old pups, pulverized on dry ice, and homoge-
nized in Trizol reagent (GIBCO BRL). RNA was extracted according to
the manufacturer’s protocol (GIBCO BRL). Total RNA (10 mg/lane) was
size-fractionated in formaldehyde agarose, transferred to Hybond nylon
membrane (Amersham Life Science), and hybridized in Rapid-hyb buffer
(Amersham Life Science) with a 39 human growth hormone fragment
unique to the transgene. Radiolabeled RNA blots were quantitated with a
PhosphoImager (Molecular Dynamics) and each value was normalized to
b-actin expression (human b-actin cDNA control probe; CLONTECH).
Protein. Levels of CPb1, CPb2, and CPa protein were assayed by im-
munoblotting using SDS polyacrylamide gel and two dimensional electro-
phoresis of mouse hearts with isoform specific antibodies as previously de-
scribed (Schafer et al., 1994). The differences in mass and pI of mouse a1
(32.7 kD, 5.3); a2 (32.9 kD, 5.7); b1 (30.6 kD, 5.5); b2 (31.4 kD, 5.8); and
b1-L262R (30.6 kD, 5.8) polypeptides were the basis for their identifica-
tion. Blots were probed with isoform-specific polyclonal antibodies to b1
(R33) and b2 (R25), a pan b antibody (R22), and an mAb (5B12) that rec-
ognizes the a1 and a2 isoforms equally well (Schafer et al., 1994; Hart et
al., 1997).
For the SDS polyacrylamide gels, two whole heart extracts from each
transgenic line were prepared in SDS sample buffer. Approximately equal
amounts of protein were run on 15% SDS-polyacrylamide gels. One gelHart and Cooper CPb Isoform Function 1289
was stained with Coomassie blue to confirm equal protein loading for
each sample and the other gels were transferred to nitrocellulose and
probed. The immunoblots were developed as described (Schafer et al.,
1994) and scanned to obtain a digital image. The b1 and b2 protein were
quantitated using NIH image and compared with the signal intensities of
immunoblots of known concentrations of purified b1 and b2 probed with
the same antibody (Schafer et al., 1998). These measurements were nor-
malized to the amount of protein loaded on the gels. For statistical pur-
poses, Western blot analyses of proteins were performed twice with each
sample and mean 6 values calculated.
Heart/Body Weight Ratios
Transgenic mice and their nontransgenic littermates, from 9–180-d-old,
were anesthetized. Their beating hearts were excised, rinsed, drained of
fluid, and weighed. Heart/body weight ratios were calculated and ex-
pressed as mg:g.
Preparation of Samples for Microscopic Examination
Hearts were excised and fixed overnight in 10% buffered formalin. The
hearts were cut in half along a midsagittal plane, paraffin-embedded, and
sectioned. Sections were stained with hematoxylin and eosin. For immu-
nofluorescence, sections were deparaffinized with xylene and rehydrated
through a series of graded alcohol washes to distilled water. Sections were
labeled with antibodies to CPb1 (R33), CPb2 (R25), actin (C4, a gift of
Dr. J. Lessard, University of Cincinnati), and vinculin (Sigma Immu-
nochemicals). Primary antibodies were detected by fluorescently tagged
secondary goat anti–rabbit (Cy3; Jackson ImmunoResearch Laboratories)
or goat anti–mouse antibodies (DTAF; Sigma Immunochemicals). Sec-
tions were mounted in N-propylgallate/glycerol mounting media. Immu-
nofluorescence microscopy was performed on an epifluorescence micro-
scope (IX70; Olympus) with a 1.35 NA 1003 UPlanApo objective and
U-MWIBA (DTAF) and U-MNG (Cy3) filter sets. Images were collected
with a cooled CCD video camera (RC300, Dage-MIT).
For EM, hearts were fixed in 2.5% glutaraldehyde, 100 mM calcium ca-
codylate overnight. A section of the left ventricular wall parallel to the
papillary muscle was removed. This section was postfixed in 1.25% os-
mium tetraoxide, stained en bloc with 4% uranyl acetate, embedded in
Polybed (Polysciences), sectioned, and stained with 4% uranyl acetate/
Reynold’s lead citrate. Thin sections were examined using a Zeiss 902
electron microscope.
Results
CPb2 Cannot Functionally Replace CPb1
To test if CPb2 can functionally replace CPb1 in organiz-
ing the thin filaments at the Z-lines of the sarcomere, we
used the a-MyHC to express the CPb2 isoform in the
mouse myocardium. These transgenic lines are referred to
as TG-wtb2. The well-characterized a-MyHC promoter
directs strong and specific expression in the murine ventri-
cles beginning at birth. It is not expressed in smooth or
skeletal muscle, or in the ventricular chamber during de-
velopment (Palermo et al., 1995, 1996; Robbins et al.,
1995).
Gross Phenotype
Three TG-wtb2 founders were identified. None of the
founders demonstrated any gross phenotype, reduced via-
bility, or reduced fertility. Backcrossing of the TG-wtb2
founders produced heterozygous N1 offspring. N1 prog-
eny from two of the founders (2 and 3) showed severe ef-
fects. The transgenic mice exhibited stunted growth and an
irregular gait beginning at approximately seven days after
birth. They expired at 7–26 d after birth (Fig. 1). No pe-
ripheral edema was noted, but breathing appeared labored
for several days before death. The phenotype was com-
pletely penetrant, with 100% of heterozygous N1 trans-
genic mice from these two founders displaying the de-
scribed phenotypes (Fig. 1).
Because the founders were heterozygous for the trans-
gene insertion, we anticipated 50% of the N1 progeny
would be heterozygous for the transgene insertion. How-
ever, heterozygous transgenic N1 progeny with the severe
phenotype represented only 20–35% of the litter, suggest-
ing that these founders were chimeric for the transgene in-
sertion. In z20–30% of transgenic mice, the foreign DNA
is presumed to integrate at a later stage, resulting in trans-
genic mice that are mosaic for the transgene (Wilkie et al.,
1986). This hypothesis can also account for the fact that
the founders had far less severe cardiac phenotypes than
the transgenic N1 progeny.
To test whether the phenotype of the TG-wtb2 mice was
due to defective interaction of the actin-based thin fila-
ments with CP at Z-lines, we generated transgenic mice
expressing a dominant negative point mutation of CPb1.
These transgenic lines are referred to as TG-b1L262R.
This mutation changes amino acid residue 262 from leu-
cine to arginine and lowers the actin-binding affinity by a
factor of 104 (Barron-Casella et al., 1995). Four founders
were identified. None of the founders exhibited any dis-
cernable gross phenotype. There was no reduction in via-
bility or fertility.
The phenotype of the N1 TG-b1L262R heterozygotes
(TG-b1L262R lines 2 and 3) was similar to that of the
N1 TG-wtb2 heterozygotes. These mice showed stunted
growth, an irregular gait, labored breathing, and death at
7–26 d after birth (Fig. 1). This phenotype was almost
completely penetrant (16/17 animals). In contrast to the
Figure 1. Life span of transgenic mice (wild-type, n 5 66; TG-
wtb1, n 5 34; TG-wtb2, n 5 18; TG-b1L262R, n 5 17). The dates
of mice found dead or very near death (animals immobile with la-
bored breathing) were recorded and used to determine the life
span of the transgenic mice. Each data point indicates the per-
centage of animals alive at that day after birth. TG-wtb1 and
wild-type mice shared an identical profile, neither having a re-
duction in viability. In contrast, TG-wtb2 (lines 2 and 3) and TG-
b1L262R (line 2) mice died between 7–26 d after birth.The Journal of Cell Biology, Volume 147, 1999 1290
TG-wtb2 heterozygotes, one eye often failed to open in the
TG-b1L262R heterozygotes, presumably due to a-MyHC’s
weak expression in the ocular musculature (Sussman et al.,
1998).
To determine if the TG-wtb2 and TG-b1L262R pheno-
type could be caused by increased expression of CPb pro-
tein in general, we used the same approach to generate
transgenic mice that overexpress the CPb1 isoform. These
transgenic lines are referred to as TG-wtb1. Three found-
ers were identified. Neither the founders, nor the N1 het-
erozygotes, exhibited any of the gross phenotypes as ob-
served in the TG-wtb2 transgenic mice (see CPb1 Cannot
Functionally Replace CPb2).
RNA Expression
To confirm the integrity of the transgenic transcript and to
quantify transgene expression, Northern blot analysis us-
ing a transgene-specific probe was performed on total
RNA from hearts obtained from transgenic and nontrans-
genic littermates.
Nontransgenic animals showed zero expression of the
transgene, as expected. All the TG-wtb2 transgenic lines
showed expression. Line 1 showed the lowest level of ex-
pression. Line 2 expression was approximately fourfold
that of line 1. Line 3 expression was z4.5-fold that of
line 1 (Fig. 2). N1 heterozygotes from lines 2 and 3 had the
previously described strong gross phenotype whereas
transgenic line 1 did not. Therefore, transgene transcript
accumulation correlated with the severity of the gross phe-
notype.
Similarly, in the TG-b1-L262R lines, the levels of trans-
gene expression correlated with the severity of the pheno-
type. A strong heterozygote (line 2) expressed the trans-
gene approximately fourfold more than a weak line (line 1;
Fig. 2).
Protein Expression
To determine the level of protein expression of the CPb1
and CPb2 isoforms in the hearts of TG-wtb2, TG-
b1L262R, and TG-wtb1 mice, myocardial protein was
quantified by immunoblot with isoform-specific and pan-
reactive antibodies.
TG-wtb2.  For the TG-wtb2 lines, an increased level of
CPb2 protein was observed in all of the transgenic lines
(Fig. 3, anti-b2). The level of CPb2 protein varied from ap-
proximately two- to fourfold that of the wild-type endoge-
nous level. The amount of transgenic protein correlated
with the level of transgene transcript, with line 3 contain-
ing the highest levels of protein and transcript. Overex-
pression of b2 led to a decrease in the level of b1 (Fig. 3,
anti-b1). The total amount of CPb and CPa did not
change (Fig. 3, anti-panb, anti-pana). Therefore, the level
of active heterodimer was constant, with an increased ratio
of a:b2 to a:b1.
TG-b1L262R. To determine the CPb isoform protein ex-
pression in TG-b1L262R lines, two-dimensional immuno-
blots were required to identify the b isoforms (Fig. 4). Al-
though the b1 and b1-L262R polypeptides have similar
molecular masses, the b1-L262R mutation shifts the pI
from 5.5 to 5.8 and then can be discriminated from wild-
type (see Fig. 4, cartoon). The blots were also probed with
an mAb pan-reactive to a1 and a2.
An increased level of the transgenic protein was ob-
served in hearts of TG-b1L262R animals that have both a
Figure 2. Transgene expression in the TG-wtb1, TG-wtb2, and
TG-b1L262R founder lines. The lines show different levels of ex-
pression, which correlate with the severity of the phenotype. TG-
wtb1, line 3; TG-wtb2, lines 2 and 3; and TG-b1L262R, line 2 are
described further in the paper.
Figure 3. Expression of CPa, CPb1, and CPb2 in TG-wtb1 and
TG-wtb2 lines. A, The expression of the TG-wtb1 and TG-wtb2
lines was determined from Western blots probed with anti-b1,
anti-b2, anti-panb, and anti-pana antibodies. B, The intensity of
the bands on the blots corresponding to the b1 and b2 proteins
was quantitated and compared with the signal intensities of im-
munoblots of known concentrations of purified b1 and b2 probed
with the same antibody. Error bars represent SEM.Hart and Cooper CPb Isoform Function 1291
strong (line 2) and a mild (line 1) phenotype (Fig. 4, anti-
panb). The severity of the phenotype correlated with the
amount of protein expressed. The increased expression of
the  b1-L262R polypeptide was accompanied by a de-
creased level of the endogenous b1 subunit (Fig. 4, B and
C) and a complete loss of the b2 subunit (Fig. 4, E and F).
There was no change in the level of the CPa subunit
expression. Therefore, overexpression of the b1-L262R
polypeptide changed the ratio of the isoforms in the het-
erodimer population with an increase of a:b1-L262R and a
decrease in a:b1 and a:b2.
TG-wtb1. For the TG-wtb1 lines, an increased level of
the CPb1 protein was seen in all the transgenic lines (Fig.
3). The increased level of CPb1 protein in the TG-wtb1
lines was similar to the increased level of CPb2 protein
seen in the TG-wtb2 lines, when considered as a ratio with
respect to wild-type, and was substantially increased when
considered in absolute terms. The TG-wtb1 lines did not
show the severe phenotypes of sarcomere disruption and
hypertrophic cardiomyopathy seen in the TG-wtb2 lines
(described in detail in CPb1 Cannot Functionally Replace
CPb2). Therefore, the severe phenotype of the TG-wtb2
mice was specifically caused by the increased level of
CPb2 protein, and could not be explained by an increased
level of b subunit protein in general.
Morphology of the Heart
Gross Morphology. To determine if overexpression of CPb2
and CPb1-L262R in the murine myocardium leads to car-
diac hypertrophy, cardiac weights corrected for body weight
were determined for the TG-wtb1 and TG-b1L262R mice
(Table I). TG-wtb2 and TG-b1L262R mice had elevated
heart to body weight ratios relative to control littermates,
z30% larger than ratios for nontransgenic mice. There-
fore, overexpression of CPb2 and CPb1-L262R caused
cardiac hypertrophy.
Light microscopic analysis of hematoxylin- and eosin-
stained heart sections of TG-wtb2 (lines 2 and 3) and TG-
b1L262R (lines 2 and 3) revealed global dilation of the
hearts of transgenic, compared with nontransgenic con-
trols (Fig. 5 A). The walls of the ventricles were thickened
throughout the chambers. The chambers were not grossly
dilated.
Ultrastructure of the Myocardium. To determine if car-
diac hypertrophy was accompanied by an altered morphol-
ogy of myofibrils and sarcomere structure, the ventricular
walls of control animals (nontransgenic littermates) and
transgenic mice were examined by light microscopy and
thin section EM.
Figure 4. The expression of CPb1, CPb1-L262R, CPb2, and CPa
in TG-b1L262R lines. The expression of TG-b1L262R lines was
determined by two-dimensional immunoblots probed with anti-
pana, anti-b1, and anti-b2. The b1 and b1-L262R polypeptides
have a similar molecular mass, but different pI’s, 5.5 and 5.8, re-
spectively.
Table I. Cardiac Hypertrophy Based on Heart Weight
Heart/body wt n
mg/g
Wild-type 6.8 6 0.3 19
TG-wtb1 6.0 6 0.4 7
TG-wtb2 9.8 6 0.8 7
TG-b1L262R 10.6 6 1.0 9
Heart to body wt ratios are listed as mean 6 SEM. n is the number of animals.
Figure 5. Transgenic mouse hearts exhibit histopathological fea-
tures of concentric hypertrophy. A, Hematoxylin- and eosin-
stained sections show an enlarged heart with thickened left
ventricles relative to nontransgenic littermates. B, At higher
magnification, the walls of wild-type mice show striations (ar-
rows) reflecting well-ordered periodicity and alignment of myo-
fibrils. The walls from the TG-wtb2 mice (lines 2 and 3) show no
periodicity. Nuclei are enlarged in the TG-wtb2 samples as
well. Bar, 5 mm.The Journal of Cell Biology, Volume 147, 1999 1292
Light microscopic analysis of ventricular walls of non-
transgenic mice showed the characteristic pattern of stria-
tions. The striations are observed due to the periodicity of
the repeating sarcomere units and because the myofibrils
are aligned with each other laterally. In contrast, the ven-
tricle wall of the TG-wtb2 hearts revealed loss of the stria-
tions. Also, the size of the myocyte nuclei was increased
(Fig. 5 B).
In thin section EM, the hearts from wild-type animals
had myofibrils aligned laterally from Z-line to Z-line, with
distinct A and I bands, and Z- and M-lines (Fig. 6). Mito-
chondria had an elongated shape and were between the
parallel arrays of myofibrils.
In TG-wtb2 mice, gross myofibrillar disarray was appar-
ent. The myocytes were arranged in chaotic patterns at
oblique and perpendicular angles. In the sarcomere, the
I band was difficult to identify. The A band appeared
to span the entire length between highly disorganized
Z-lines. The Z-lines were truncated, wavy, and appeared
slightly thickened. In some areas, the Z-lines were lacking
entirely. The myofibrils were filled with numerous swollen
mitochondria.
The intercalated discs of the TG-wtb2 myocardium had
a relatively normal ultrastructure, but were increased in
number and decreased in length. To confirm this result, in-
tercalated discs were examined by light microscopy using
Figure 6. Electron micrographs of thin sections of the left ventricles of control, TG-wtb1, TG-wtb2, and TG-b1L262R animals. Myo-
fibrils of controls are well-organized with periodicity along their length and lateral alignment. The myofibrils of TG-wtb2 (lines 2 and 3)
and TG-b1L262R (line 2) were poorly organized, with short or absent Z-lines. The intercalated discs of controls consist of closely op-
posed, transversely oriented plasma membranes. The intercalated discs of TG-wtb1 and TG-b1L262R mice showed a loss of organiza-
tion.Hart and Cooper CPb Isoform Function 1293
antivinculin to show the intercalated discs. In normal myo-
cardium, antivinculin staining was found as a fine line at
the intercalated discs and weakly at the border of the myo-
cytes (see Fig. 11). In TG-wtb2 myocardium, vinculin la-
beling appeared as small irregular lines consistent with the
multiplicity of intercalated discs in ultrastructure analysis.
This could be due to the addition of new intercalated discs
or fragmentation of existing discs caused by the underlying
myofibril dysgenesis (see Discussion).
Abnormal cardiomyocyte structure and organization was
also apparent in the left ventricles of TG-b1L262R mice,
whose mutation precludes the binding of actin to CP (Figs.
6 and 7). This suggests that the myofibrillar disarray ob-
served in the hearts of the TG-wtb2 mice was due to the in-
ability of CPb2 to attach the actin filaments to the Z-line.
The myofibrils of TG-b1L262R had a highly disorganized
architecture, including abnormally registered sarcomeres
with disoriented or missing Z-lines. The A and I bands
were apparent, but lacked their typical striation. The mito-
chondria had lost their organization and shape.
Analysis of the myocardium of eight-day-old TG-
b1L262R mice showed milder defects, confirming that the
myocyte deterioration was progressive from birth as ex-
pected (Fig. 7). At eight days after birth, the periodicity of
the Z-lines, the registration of the Z-lines, and the align-
ment of the myofibrils were only slightly altered. Higher
magnification showed minor deterioration of the sarco-
meres with thinning of the Z-line.
CPb Protein Localization in Transgenic Hearts
The distribution of the CPb1 and CPb2 isoforms in murine
heart tissue is the same as that described previously for
chicken heart tissue and cultured cardiomyocytes (Schafer
et al., 1994). CPb1 is at the Z-lines of the sarcomere (Fig. 8
A). CPb2 is at intercalated discs and in a punctate pattern
(Fig. 8 C).
TG-wtb2. Two alternative hypotheses can explain the in-
ability of CPb2 to functionally replace CPb1 and organize
the thin filaments at the Z-line in the TG-wtb2 mice. The
first is that b2 may not localize to the Z-line due to a lack
of targeting information. The second is that b2 may local-
ize to the Z-line, but not bind to and correctly orient the
thin filaments there. To discriminate between these alter-
natives, the localization of CPb2 in TG-wtb2 hearts was
determined.
In TG-wtb2 hearts, CPb2 localized to the periphery of
the myofibrils and in a punctate pattern (Fig. 9). Because
the Z-lines were truncated and wavy, we used double im-
munofluorescence labeling with antiactin to identify the
Z-line (Fig. 10). Double immunofluorescence labeling
with anti-b2 revealed that CPb2 did not localize to the
Z-line in the TG-wtb2 myocardium. This suggests that CPb2
is unable to functionally replace b1 at the Z-line due to its
inability to localize to the Z-line.
Western blot analysis showed a decreased level of b1
protein in the TG-wtb2 hearts. To confirm this result and
Figure 7. Progressive disorganization. Myofibrils from TG-
b1L262R mice (line 2) show progressive disorganization, with
milder defects at early times (A and B higher magnification) and
poor myofibrillar organization by day 20 (C). Bars, (A and C) 1.1
mm; (B) 0.35 mm.
Figure 8. Immunofluorescence staining of the CPb isoforms (A
and C) and corresponding DIC images (B and D) in sections of
wild-type hearts. The b1 isoform localizes predominantly to the
Z-lines (A). The b2 isoform localizes to intercalated discs and in
a punctate pattern at cell–cell junctions (C). Bar, 5 mm.The Journal of Cell Biology, Volume 147, 1999 1294
determine the localization of b1 in the TG-wtb2 hearts, we
examined the localization of the b1 isoform with anti-b1.
In TG-wtb2 hearts, b1 was observed as weakly stained
truncated Z-lines and in a punctate pattern. The weak
level of staining was consistent with the decreased level of
b1 seen in Western blot analysis. The truncation of Z-lines
was consistent with the myofibril dysgenesis observed in
thin section EM (Fig. 9).
TG-b1L262R. b1-L262R is a mutant form of the b1 sub-
unit that binds actin poorly in vitro. We hypothesized that
in TG-b1L262R hearts, the mutant b1 protein would local-
ize to the Z-line, but be incapable of binding actin fila-
ments, as expected from its biochemical properties. To de-
termine if b1-L262R protein was able to localize to the
Z-lines in transgenic hearts, we examined the localization
of b1-L262R with anti-b1. b1-L262R protein did localize
to the Z-line, appearing as short, wavy lines, reflecting the
loss of the parallel alignment of the Z-lines seen by EM
(Fig. 9).
To confirm that the level of b2 protein was reduced in
TG-b1L262R hearts, as seen in Western blot analysis, and
to examine the localization of b2, we stained heart sections
with anti-b2. The intensity of b2 staining was decreased, as
expected. b2 localized in a punctate pattern and at cell–
cell junctions.
CPb1 Cannot Functionally Replace CPb2
We found that CPb2 could not functionally replace CPb1
Figure 9. Immunofluorescence staining of CPb1 and CPb2 iso-
forms and corresponding DIC images in TG-wtb1 (line 3), TG-
wtb2 (line 2), and TG-b1L262R (line 3) hearts. In TG-wtb1
myocardium, CPb1 localized to the Z-lines, in a pattern that ap-
peared slightly wider than wild-type. CPb1 staining intensity was
not increased at the intercalated disc (arrow), relative to Z lines.
CPb2 localized to cell–cell junctions, the cell cortex, and in a
punctate pattern. In TG-wtb2 myocardium, CPb1 localized to in-
complete Z-lines; CPb2 localized to the cell cortex and in a punc-
tate pattern. In TG-b1L262R hearts, CPb1L-262R protein local-
ized to wavy, fragmented Z-lines (arrows) and in a punctate
pattern. Bar, 5 mm.
Figure 10. Double immunofluorescence localization of actin and
CPb2 in TG-wtb2 hearts. Antiactin binds the Z-lines. In TG-
wtb2 (lines 2 and 3) hearts, actin localization at the Z-line was
wavy and discontinuous, reflecting the decreased organization of
the myofibrils and sarcomeres. b2 localized in a punctate pattern.
The merged image shows that b2 does not colocalize with actin at
the Z-line in TG-wtb2 hearts. Bar, 5 mm.Hart and Cooper CPb Isoform Function 1295
in organizing the actin filaments at the Z-line. We next
asked the converse question, whether CPb1 could func-
tionally replace CPb2 in organizing the actin cytoskele-
ton–membrane interactions at intercalated discs. To test
this hypothesis, we expressed the CPb1 isoform in the
mouse myocardium using the a-MyHC promoter. Trans-
genic lines are referred to as TG-wtb1. Three founders
were identified. Neither the founders nor the N1 heterozy-
gotes exhibited any gross phenotype or reduced viability
(Fig. 1).
RNA Expression
All of the transgenic TG-wtb1 lines showed expression
(Fig. 2). TG-wtb1 line 1 had the lowest level. Expression in
line 2 was twofold that of line 1, and expression in line 3
was tenfold that of line 1. Nontransgenic littermates
showed no expression.
Protein Expression
An increased level of CPb1 protein was observed in all of
the TG-wtb1 lines, from about two- to fourfold that of en-
dogenous CPb1 in nontransgenic littermates (Fig. 3). The
level of transgenic protein correlated with the level of
transgene transcript. Line 3 expressed the highest levels of
protein and transcript.
Overexpression of CPb1 led to an increase in the total
amount of CPb subunit expressed (Fig 4, anti-panb). The
level of the b2 subunit did not change. Importantly, the
level of the a1 and a2 subunits did not change. Therefore,
the level of active heterodimer was constant, with an in-
creased ratio of a:b1 to a:b2.
Morphology of the Heart
Gross Morphology. To determine if overexpression of CPb1
in the murine myocardium caused cardiac hypertrophy,
heart weights were measured and corrected for body
weight (Table I). TG-wtb1 mice did not have elevated
heart to body weight ratios relative to control littermates.
Therefore, in contrast to overexpression of CPb2 and
CPb1-L262R (see above), overexpression of CPb1 did not
cause cardiac hypertrophy.
Light microscopic analysis of hematoxylin- and eosin-
stained heart sections of the CPb1 transgenic mice showed
a normal structure of the heart with no enlargement of
ventricular walls or chambers (data not shown).
Ultrastructure of the Myocardium. To determine if there
was an altered morphology of intercalated discs or myo-
fibrils in the TG-wtb1 hearts, ventricular walls were exam-
ined by thin section EM. In TG-wtb1 myocardium, the
intercalated discs were fragmented, composed of short,
disjointed segments that were misaligned relative to the
orientation of the myofibrils (Fig. 6). The density of the
electron-dense segment parallel to the plasma membrane
was diminished. The segment was also discontinuous along
its length.
The registration and morphology of the sarcomeres of
the TG-wtb1 myocardium were largely unremarkable
(Fig. 6). The Z-lines of the sarcomere were more electron
dense and slightly thickened, which may be caused by the
increased level of CPb1 protein seen in Western blot anal-
ysis (Fig. 3).
Since this phenotype was relatively mild compared with
expression of b2, we considered that the b1 isoform might
be functioning at the intercalated disc. To address this
question, we examined the intercalated discs of transgenic
mice expressing a mutant form of the b1 subunit, TG-
b1L262R, that should not function because it binds actin
poorly in vitro. The TG-b1L262R mice showed interca-
lated disc remodeling similar to that of the mice expressing
the wild-type b1 isoform, with fragmentation of the inter-
calated disc and a reduction of electron-dense material
parallel to the plasma membrane. The intercalated discs
were also examined by light microscopy using antivinculin
to show the intercalated discs. In TG-wtb1 and TG-
b1L262R myocardium, vinculin labeling at the interca-
lated discs appeared as slightly thickened, skewed lines,
consistent with the misalignment of the intercalated discs
seen in ultrastructure analysis (Fig. 11). Therefore, the
wild-type  b1 isoform appears not to function at all in place
of the b2 isoform at the intercalated disc.
CPb1 Does Not Accumulate at the Intercalated Discs 
of TG-wtb1 Hearts
Two alternative hypotheses can explain the inability of
CPb1 to functionally replace CPb2 and organize the thin
filaments at the intercalated discs in TG-wtb1 mice. The
first is that b1 may not localize to the intercalated disc.
The second is that b1 may localize to the intercalated disc,
but not bind to and correctly orient the thin filaments
there. To discriminate between these alternatives, the lo-
calization of CPb1 in TG-wtb1 hearts was determined.
Intercalated discs do contain Z-lines from each of the
adjoining myocytes. CPb1 is present at the intercalated
disc for that reason, but its staining intensity is not in-
creased relative to other Z-lines in the myofibril. In con-
trast, CPb2 is seen at the intercalated discs, but not at
Z-lines (Schafer et al., 1994; Fig. 8).
In TG-wtb1 myocardium, b1 localized to the Z-lines of
the sarcomeres, including the Z-line component of the in-
tercalated discs, in a slightly broader pattern than in wild-
type (Fig. 9). However, b1 staining intensity was not in-
creased at the intercalated discs. This result suggests that
CPb1 is unable to functionally replace b2 at the interca-
lated disc due to its inability to localize to the intercalated
disc.
Discussion
The CPb Isoforms Are Functionally Distinct in the 
Murine Myocardium
CP, an a/b heterodimer, is a component of the actin cy-
toskeleton in all eukaryotes (Schafer et al., 1994; Hop-
mann et al., 1996; Hart et al., 1997). Vertebrates contain
three a subunit isoforms (a1,  a2, and a3) encoded by
three different genes and three b subunit isoforms (b1, b2,
and b3), which are produced from one gene by alternative
splicing.
The sequences of the b1 and b2 isoforms are highly con-
served across vertebrates and the b1 and b2 isoforms show
different expression and localization patterns (Schafer et al.,
1994). In myocytes, b1 is a component of the Z-lines ofThe Journal of Cell Biology, Volume 147, 1999 1296
sarcomeres and b2 is a component of cell–cell junctions,
where myofibrils associate with the plasma membrane.
We considered two hypotheses to explain why the b1
and b2 isoforms have conserved sequence differences and
unique expression patterns in myocytes. One hypothesis is
that the b1 and b2 isoforms are functionally equivalent,
but have acquired different expression patterns important
for muscle differentiation. This hypothesis predicts that
the b1 isoform can replace the function of the b2 isoform
and that the b2 isoform can replace the function of the b1
isoform. To test this hypothesis, we shifted the b1:b2 iso-
form ratio in the mouse heart using expression from a car-
diac specific promoter. Our findings exclude this hypothe-
sis because differences in the b1:b2 isoform ratio changed
the morphology and physiology of the heart.
Another hypothesis is that the b isoforms have acquired
novel biochemical functions and fulfill different roles
within the heart. This hypothesis predicts that an increase
in the b2 isoform will lead to an alteration in the structure
and function of the sarcomeres, which contain b1, and that
an increase in b1 will lead to an alteration in the structure
and function of the intercalated discs, which contain b2. Our
findings support this hypothesis. We found that b2 cannot
replace b1 at the Z-line. Expression of wild-type b2 sub-
unit or an actin-binding mutant form of b1 caused major
structural defects in sarcomere organization, leading to
cardiac hypertrophy and juvenile lethality. We also found
that b1 cannot replace b2 at the intercalated disc. Expres-
sion of wild-type b1 subunit or an actin-binding mutant
form of b1 caused structural defects in the intercalated
discs.
Overexpression of CPb2 or an Actin-Binding Mutant of 
CPb1 Causes Hypertrophic Cardiomyopathy
In striated muscle, interactions among actin thin filaments
and various contractile proteins contribute to the highly
ordered structure and function of muscle. The actin thin
filaments of the sarcomere are attached to Z-lines. CP
binds the barbed ends of the thin filaments at the Z-line,
maintaining the actin filament location, polarity, and
length.
We found that inhibiting CP’s ability to attach the
barbed end of an actin filament to the Z-line has severe ef-
fects on sarcomere assembly in mice, consistent with the
effects seen in cultured cells (Schafer et al., 1995). Trans-
genic mice that overexpress the b2 isoform or an actin-
binding mutant of the b1 isoform showed juvenile lethality
with severe disruption of myofibril architecture and car-
diac hypertrophy. This result argues that the isoform-spe-
cific function of CPb1 is to maintain the organization of
the sarcomere by attachment of thin filaments to the Z-line.
Presumably, the loss of b1 function leads to a loss in the
number of thin filaments that can be attached to a Z-line,
leading to myofibrillar disarray.
The overexpressed wild-type b2 subunit did not localize
to the Z-line. This suggests that the unique function of the
b1 isoform involves interacting with additional compo-
nents of the Z-line, not only actin. This conclusion is also
supported by previous work on cultured cells, where an
anti-CPb1 antibody that prevents the binding of CP to ac-
tin was observed to localize to the Z-line (Schafer et al.,
1995). Together, these results indicate that CPb1 binds
Z-lines independent of actin, by some additional interac-
tion. The components responsible for the isoform-specific
interaction remain to be defined. Potential candidates in-
clude other sarcomere components present at the Z-line,
Figure 11. Immunofluorescence localization of vinculin in wild-
type, TG-wtb1 (line 3), TG-wtb2 (lines 2 and 3), and TG-
b1L262R (line 3) hearts. In wild-type myocardium, vinculin lo-
calized to a line at the intercalated discs (arrow) and weakly at
the border of the myocytes. In TG-wtb1 and TG-b1L262R
hearts, the localization of vinculin to the intercalated disc was a
curved line (arrow) that was not transverse relative to the orien-
tation of the myofibrils. In TG-wtb2 hearts, vinculin localized to
intercalated discs in small truncated lines (arrows). Bar, 5 mm.Hart and Cooper CPb Isoform Function 1297
such as titin (Pierobon et al., 1989; Soteriou et al., 1993),
a-actinin (Papa et al., 1999), and nebulin (Keller, 1995).
Our studies define CPb1 as a sarcomeric protein for
which mutation can cause hypertrophic cardiomyopathy, a
disorder characterized by increased left ventricular mass
and myofibrillar disarray. Familial hypertrophic cardio-
myopathy in humans is caused by mutations in genes
encoding sarcomeric proteins, including a-cardiac actin
(Mogensen et al., 1999), b-myosin heavy chain (Geisterfer-
Lowrance et al., 1990; Tanigawa et al., 1990), troponin T,
a tropomyosin (Thierfelder et al., 1994), myosin-binding
protein C (Bonne et al., 1995; Watkins et al., 1995b), myo-
sin essential light chain, myosin regulatory light chain
(Poetter et al., 1996), and troponin 1 (Kimura et al., 1997).
In addition, dilated cardiomyopathy can be caused by mu-
tations in actin (Olson et al., 1998). These actin mutations
are hypothesized to affect attachment of thin filaments to
the Z-line. The relationships between cardiac hypertrophy
and dilatation, and the mechanisms that lead to each
of these responses, are being explored in mouse models
and humans with cardiomyopathies (Chien, 1999). Using
transgenesis, we have generated a new mouse model dis-
playing hypertrophic cardiomyopathy, based on defective
thin filament/Z-line attachment. Mutations in CP genes,
therefore, merit consideration as causes of human cardio-
myopathies.
Overexpression of CPb1 and an Actin-Binding Mutant 
of b1 Isoform Causes Altered Intercalated
Disc Morphology
Ventricular cardiac muscle cells of the myocardium are
connected to one another at their ends by the intercalated
disc. The intercalated disc links the Z-lines of adjacent myo-
fibrils and the plasma membranes of adjacent myocytes to
one another. The intercalated disc ensures that upon contrac-
tion, mechanical tension is efficiently transmitted through
the myocardium (Watkins et al., 1995a).
We found that overexpression of CPb1 or an actin-bind-
ing mutant form of CPb1 caused changes in the structure
of the intercalated disc in the myocardium. The interca-
lated discs of TG-wtb1 and TG-b1L262R hearts were dis-
jointed and misaligned relative to the orientation of the
myofibrils. Presumably, the altered discs were weakened
by the loss of CPb2 and then fragmented in response to
contraction.
Multiplicity of Intercalated Discs in
TG-wtb2 Myocardium
Overexpression of CPb2 led to the formation of multiple
truncated intercalated discs in the myocardium; the mor-
phology of the intercalated discs was otherwise normal. The
increased number of intercalated discs could be a second-
ary effect of the underlying myofibril dysgenesis or to in-
creased stress that accompanies hypertrophy (Sepp et al.,
1996). However, multiple truncated intercalated discs
were not seen in the TG-b1L262R myocardium, in which
loss of CPb1 function caused prominent myofibril dysgen-
esis. This result does not support the hypothesis that
myofibril dysgenesis alone can cause multiple truncated
intercalated discs, as seen in TG-wtb2 myocardium. Al-
ternatively, the multiplicity of intercalated discs may, in
TG-wtb2 mice, be due the increased level of CPb2, which
is a component of the intercalated disc, having dominant
effects on other components of the intercalated disc.
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